MAGGIE ROSS: Open Payments
NPI 1245276286 · ALMA, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$394 in 18 payments from 9 companies in 2025. Trend: 2023 $261 · 2024 $414 · 2025 $394
Food & beverage: $394
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 4 | $104 |
| Otsuka America Pharmaceutical, Inc. | 4 | $91 |
| Janssen Pharmaceuticals, Inc | 2 | $43 |
| Lundbeck LLC | 2 | $40 |
| Neurocrine BioSciences, Inc. | 2 | $31 |
| E.R. Squibb & Sons, L.L.C. | 1 | $26 |
| Teva Pharmaceuticals USA, Inc. | 1 | $22 |
| ABBVIE INC. | 1 | $21 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
Products named: ARISTADA, REXULTI, ABILIFY ASIMTUFII, INGREZZA, COBENFY, ABILIFY MAINTENA, INVEGA SUSTENNA, VRAYLAR.
Industry payments across MI — which companies pay providers there.
